|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Pfizer
|
|
gptkbp:acquired
|
gptkb:Pfizer
by Pfizer
|
|
gptkbp:acquisition
|
acquired by Pfizer in 2000
expanded Pfizer's portfolio
|
|
gptkbp:business_model
|
off-patent drugs
|
|
gptkbp:ceo
|
Michael Goettler
|
|
gptkbp:collaborated_with
|
gptkb:Pharmacia_&_Upjohn
|
|
gptkbp:community_engagement
|
part of Pfizer's programs
|
|
gptkbp:dissolved
|
gptkb:2003
|
|
gptkbp:employees
|
part of Pfizer's workforce
|
|
gptkbp:financial_performance
|
part of Pfizer's financials
|
|
gptkbp:focus
|
off-patent medicines
|
|
gptkbp:founded
|
gptkb:Upjohn_Company
1886
|
|
gptkbp:founder
|
gptkb:William_H._Upjohn
|
|
gptkbp:global_presence
|
part of Pfizer's global operations
|
|
gptkbp:headquarters
|
gptkb:Kalamazoo,_Michigan
gptkb:Michigan
Kalamazoo
Viatris, Kalamazoo, Michigan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Upjohn
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:key_people
|
gptkb:Robert_W._Upjohn
gptkb:William_H._Upjohn
gptkb:John_W._Upjohn
gptkb:Richard_A._Henson
gptkb:David_A._Williams
gptkb:James_A._Mc_Carty
gptkb:John_W._Mc_Carty
gptkb:Robert_E._Mc_Carty
|
|
gptkbp:market
|
branded and generic pharmaceuticals
|
|
gptkbp:marketing_strategy
|
off-patent market
|
|
gptkbp:operates_in
|
global markets
|
|
gptkbp:partnerships
|
various healthcare organizations
|
|
gptkbp:products
|
gptkb:Zyban
gptkb:Procrit
gptkb:Rogaine
gptkb:Lipitor
gptkb:Lyrica
branded medications
generic medications
|
|
gptkbp:regulatory_compliance
|
follows Pfizer's standards
|
|
gptkbp:research_and_development
|
part of Pfizer's R& D
|
|
gptkbp:stock_exchange
|
part of Pfizer
|
|
gptkbp:strategic_importance
|
enhance access to medicines
|
|
gptkbp:successor
|
gptkb:Pfizer_Inc.
|
|
gptkbp:sustainability_initiatives
|
part of Pfizer's initiatives
|
|
gptkbp:type
|
gptkb:Company
|